Condie Carmack Email & Phone Number
Who is Condie Carmack? Overview
A concise factual answer block for searchers comparing this professional profile.
Condie Carmack is listed as Owner and Entrepreneur based in Greater Houston, United States. AeroLeads shows a matched LinkedIn profile for Condie Carmack.
Condie Carmack previously worked as Diagnostics Medical Science Liaison at Loxo Oncology, Inc. and Vice President of Precision Oncology at Vela Diagnostics. Condie Carmack holds Doctor Of Philosophy (Ph.D.), Pathology/Experimental Pathology from University Of Utah School Of Medicine.
About Condie Carmack
Condie Carmack is a Owner and Entrepreneur. Colleagues describe them as "Condie has built and is continuing to build a very successful business within Agilent, focussed on leveraging Agilent's microarray expertise into diagnostics. He is accomplishing this by growing and maintaining an extensive network of personal contacts within the Comparative Genomic Hybridization community. Truly someone who 'acts like an owner' in his pursuit of company goals."
Condie Carmack work experience
A career timeline built from the work history available for this profile.
Vice President Of Precision Oncology
Director Of Oncology Programs - R&D
Oversaw cutting-edge research & development efforts with responsibility for conceptualizing and designing revolutionary Next Generation Sequencing (NGS) and qPCR tests.Cultivated relationships with top molecular pathology laboratories and scientists to understand research goals, develop solutions, integrate new technology, and validate design, performance, and regulatory claims of tests. Compiled and prioritized lists of genes to provide vital information to clients. Managed laboratory… Show more Oversaw cutting-edge research & development efforts with responsibility for conceptualizing and designing revolutionary Next Generation Sequencing (NGS) and qPCR tests.Cultivated relationships with top molecular pathology laboratories and scientists to understand research goals, develop solutions, integrate new technology, and validate design, performance, and regulatory claims of tests. Compiled and prioritized lists of genes to provide vital information to clients. Managed laboratory technicians; assisted in resolving bench-level science issues.Selected Contributions:♦ Succeeded in designing four NGS oncology tests, created control reference material, and drafted submission to FDA to obtain premarket approval (PMA) for a Companion Diagnostic (CDx). Show less
General Manager, Cancer Genetics Laboratory
Led start-up operations and financial performance for CLIA-certified and CAP-accredited laboratory developing groundbreaking oncology tests.Interfaced with laboratory director, technicians, and business colleagues to design and develop tests meeting strict regulatory requirements. Seeded databases and prepared documentation. Recruited, hired, and integrated 20-member team. Managed relationships with vendors and procured equipment. Oversaw all marketing efforts to promote lab and tests… Show more Led start-up operations and financial performance for CLIA-certified and CAP-accredited laboratory developing groundbreaking oncology tests.Interfaced with laboratory director, technicians, and business colleagues to design and develop tests meeting strict regulatory requirements. Seeded databases and prepared documentation. Recruited, hired, and integrated 20-member team. Managed relationships with vendors and procured equipment. Oversaw all marketing efforts to promote lab and tests. Tracked financial and sales data to adjust marketing strategies, reimbursement structure, and staffing as needed.Selected Contributions:♦ Developed and marketed 140 LDT cancer tests within first year and offered groundbreaking NGS oncology panel test in the United States under LDT/CLIA/CAP.♦ Provided effective leadership to enable laboratory to break even within two years with $5M in business. Show less
Worldwide Molecular Diagnostic Manager
Led development of $25M market in cytogenetics converting karyotype into microarrays and navigated complex FDA/LDT requirements to market and sell to cytogenetic labs.Engaged with cytogenetic laboratories to evaluate products, prepared product technical notes, and oversaw demonstration laboratory. Directed clinical research collaborations with top universities. Coached sales team on products, clinical diagnostics, sales pitches, and FDA/CLIA compliance issues. Maintained and operated… Show more Led development of $25M market in cytogenetics converting karyotype into microarrays and navigated complex FDA/LDT requirements to market and sell to cytogenetic labs.Engaged with cytogenetic laboratories to evaluate products, prepared product technical notes, and oversaw demonstration laboratory. Directed clinical research collaborations with top universities. Coached sales team on products, clinical diagnostics, sales pitches, and FDA/CLIA compliance issues. Maintained and operated laboratory equipment. Documented and published new techniques. Received two University Relations Grants.Selected Contributions:♦ Pioneered entry into clinical diagnostics, demonstrated value proposition, and gained full support from leadership team.♦ Initiated and led development and launch of eArray Web site and CytoGenomics software still in use and profitable today.♦ Successfully grew market by 25% year-over-year for four years; led development of 50+ clinical arrays, introduced 11 RUO products/reagents, and managed royalty payments on two color array CGH for clinical applications.♦ Spearheaded innovative marketing strategies, including “RockStar” Marketing Program for clinical cytogeneticists to share array content under LDT.♦ Served as relationship manager and coordinator for International Standard Cytogenetic Array Consortium (ISCA), Cancer Cytogenomics Microarray Consortium (CCMC), NIH/Columbia Prenatal Multi-Center Array Grant, and Agendia, BV and Agendia, Inc.♦ Received distinction as Invited Chairman and Speaker at BIT’s 1st Annual Congress and Expo of Molecular Diagnostics (10/08).♦ Held contracted positions as Product and Marketing Manager for Diagnostics (5/06-10/06) and Outbound Marketing Consultant (1/05-5/06). Show less
Technical Services Senior Scientist
• Phone/Email Technical Support of RNA Amplification Product (Ribo-SPIA)• Weekly Field Pre-Sales/Technical Seminars and Talks. WebEx Seminars
Senior Applications Scientist In Microarray Division
• Provided customers with onsite training and support on microarray technologies (pin-spotter, laser scanner and software)• Assisted with system end-to-end testing, representing customer’s point of view in Marketing• Member of the PDP (Product Development Process) team. Providing scientific user requirements input into future products
Senior Research Scientist
Graduate Student
Condie Carmack education
Doctor Of Philosophy (Ph.D.), Pathology/Experimental Pathology
Master'S Degree, Microbiology And Immunology
Bachelor'S Degree, Biology/Biological Sciences, General
Post-Doctoral Training, Molecular Immunology
Frequently asked questions about Condie Carmack
Quick answers generated from the profile data available on this page.
What is Condie Carmack's role at their current company?
Condie Carmack is listed as Owner and Entrepreneur.
Where is Condie Carmack based?
Condie Carmack is based in Greater Houston, United States.
What companies has Condie Carmack worked for?
Condie Carmack has worked for Loxo Oncology, Inc., Vela Diagnostics, Baylor College Of Medicine, Agilent Technologies, and Nugen Technologies.
How can I contact Condie Carmack?
You can use AeroLeads to view verified contact signals for Condie Carmack, including work email, phone, and LinkedIn data when available.
What schools did Condie Carmack attend?
Condie Carmack holds Doctor Of Philosophy (Ph.D.), Pathology/Experimental Pathology from University Of Utah School Of Medicine.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial